Brief: Pulmatrix Sent Letter To Cipla Technologies Notifying Cipla It Is In Material Breach Of Development & Commercialization Agreement Dated April 15, 2019
May 10 (Reuters) - Pulmatrix Inc PULM.O :
* PULMATRIX - SENT LETTER TO CIPLA TECHNOLOGIES NOTIFYING
CIPLA IT
IS IN MATERIAL BREACH OF DEVELOPMENT & COMMERCIALIZATION
AGREEMENT DATED APRIL 15, 2019
* PULMATRIX - CIPLA IS IN MATERIAL BREACH OF AGREEMENT DUE
TO
ANTICIPATORY BREACH OF OBLIGATION UNDER CIPLA AGREEMENT TO FUND
50% OF DEVELOPMENT COSTS FOR PULMAZOLE
Source: (https://bit.ly/3tAR71J)
Further company coverage: PULM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulmatrix
See all newsBrief: Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger
Pulmatrix Q2 loss narrows on clinical development hold
Pulmatrix Q1 net loss narrows, clinical development on hold
Brief: Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger
NASDAQ RESUMED AT 09:00 AM